Hayden Yao-Ting Huang PhD, MPH United States

​LinkedIn Profile

http://www.linkedin.com/pub/hayden-y-t-huang/22/227/913

Memorial Sloan-Kettering Cancer Center
LinkedIn logo Principal Investigator: Patients Engagement in Clinical Trials. Co-Principal Investigator: Infections Burden on Cancer Patients 

Todd Hudson United States

TNT (Tactile Navigation Tools, LLC) creates and commercializes superior assistive technology for those with visual impairment. Currently, the tools and devices offered are antiquated and inadequate for the challenges of the visually disabled, preventing health optimization by many. 

We have tools that simplify training, increase mobility, and permit functional independence. The founder is a disability physician living with visual impairment and the team combines rehabilitation medicine, engineering, computer modeling and psychophysics.

Tactile Navigation Tools
CTO 

Olivier Jarry United States

Intrexon applies engineering principles to biology to enable products in the health, food, energy, consumer and environmental industries.  Utilizing our advanced technologies, we work with researchers, developers and marketers to design, create or modify molecules, cells, organisms and processes to solve important problems in the living world.

Intrexon Corporation
SVP Consumer Sector 

Mr Ross John United States

Seneca Nation
Councilman 

Ms Holly John United States

Seneca Diabetes Foundation
Member-Board of Directors 

Mr William Johnson United States

Boler Biotech Consulting is a Boston based biotechnology investing and consulting firm focused on early stage, private, and public Life Science companies.

We provide strategic research and analysis for investors and clients with early-stage biotechnology companies. This includes scientific assessment, due diligence, and analysis of market potential of new technologies and therapies.

We pride ourselves on identifying and partnering with startup companies and investors who successfully commercialize technologies most likely to improve the lives of patients and yield robust returns for investors.

Boler Biotech Consulting
LinkedIn logo Managing Partner 

Mr Amit Jolly United States

BioPharm Insight is your definitive guide to the healthcare community, combining an online business intelligence system of comprehensive market analytics and key industry contacts with an independent investigative journalism news service to give you an information edge. 

BioPharm Insight an acclaimed independent journalist team with a proven track record of breaking forward-looking and competitive business intelligence 6-12 months ahead of mainstream press. Based in our news bureaus in New York and London, our reporters conduct in-depth interviews with subject matter experts to ensure subscribers take action on reliable global intelligence.

Spécialisations

investigative journalism, market analytics, business intelligence, decision makers, market moving

BioPharm Insight
LinkedIn logo Healthcrae Analyst 

Dr Kevin Jones United States

Built on our patented Rapid Vertical Flow Technology™, MedMira rapid tests provide fast, accurate results. Features:
  • 3-step procedure
  • Instant results
  • Whole blood, serum or plasma specimens
  • Up to 24 month shelf-life at 2 – 30° C
  • Compact, single-use, 1.28 oz. package
  • No refrigeration required
  • Built-in procedural and reagent control line
  • Standardized procedure across all products
MedMira
Head of Commercialization 

Dr rupali joshi United States

HSS is nationally ranked #1 in orthopedics, and #3 in rheumatology by U.S.News & World Report (2015-16). HSS has been top-ranked for both orthopedics and rheumatology for the 24 consecutive years.

Because an infection can be a devastating outcome for an orthopedic patient, Hospital for Special Surgery takes infection control extremely seriously and is proud of the recognition received for our significantly low infection rates

HSS and a complement of physicians within each specialty area accepts most major insurance plans. Our Insurance Advisory Service can answer questions regarding your insurance coverage.

Hospital for special surgery
research therapist 

Dr Padideh Kamali-Zare United States

Darmiyan will offer a series of diagnostic tools aimed at early detection of complex brain diseases including neurodegenerative disorders. Darmiyan will get brain MRI data from human patients to elucidate the current condition, and which disease state the brain is progressing toward. The significance of Darmiyan’s innovation is invaluable potential to diagnose disease potential before severe symptoms develop. This novel insight originates with our technology to extract information not from the brain cells/ neurons, which exhibit abnormality only after extensive damage and cell death occurs, but from the immediate environment around them, which is called extracellular space (ECS). The ECS is often thought of as just intercellular “space,” but in reality it is the electrical and chemical pathway between all brain cells that plays an essential role in brain function and drug delivery.

Darmiyan LLC
CEO